Articles tagged with Drug Interactions
A study found that patient and kidney survival rates are comparable among donor age groups, including those over 80. Kidneys from octogenarian donors have a higher discard rate, but the difference is not significant. The results support using extended criteria donors, including older adults.
Researchers at Emory Health Sciences have made a breakthrough in understanding how diabetes drugs interact with LRH-1, a protein that regulates metabolism of fat and sugar. The study found that small changes to compounds can significantly impact their binding pocket interaction.
Researchers at Case Western Reserve University developed a portable sensor called ClotChip that can quickly and accurately assess blood's clotting ability. This technology has the potential to revolutionize the diagnosis and treatment of blood clots, allowing for faster and more precise assessments.
A new study has discovered a novel route to improve the stability of protein drugs, significantly extending their shelf life. Stability increases from 14 hours to over 100 days while maintaining activity under stressed conditions, offering potential treatment solutions for diseases in developing countries.
A new program, Live Donor Champion, has been shown to increase knowledge of live donation and comfort approaching others about live donation. The program boosted live donor referrals, with a 5.5-fold increase in having at least one donor referral compared to matched controls on the waiting list.
A new approach to solid-phase extraction of ibuprofen from pharmaceuticals has been successfully developed using zirconium dioxide as the extraction material. The procedure demonstrated efficient trapping of ibuprofen in hydrophobic suppository matrices, with recoveries of 95% and 94%, respectively.
A new computational tool called fABMACS helps scientists understand how proteins function and develop targeted therapies for diseases like cancer. By simulating chemical changes to drugs, fABMACS predicts improved drug potency and efficacy.
Chronic neurodegenerative disorders are progressively altered brain cell functions, but nanotechnology offers a solution with bio-engineered systems that interact at a molecular level. Nanomedicine improves drug efficacy with sustained release, reduced toxicity and fewer side effects.
The microbiome plays a crucial role in human health and disease, making it essential for personalized medicine. Research suggests that understanding the microbiome's interactions with genetics, environment, and lifestyle can lead to more effective treatments, including targeted therapies and antibiotics.
A study published in CMAJ found that telemedicine, including text messaging and web portals, can effectively manage diabetes by monitoring blood sugar levels and motivating patients. The use of interactive formats such as web portals or text messaging was most effective in controlling HbA1C levels.
A systematic review of 14 studies found that mobile app users with type 2 diabetes experienced a reduction in average blood glucose levels, with an approximate 0.5% decrease in HbA1c. Younger patients reported more benefits from using apps.
The International Climbing and Mountaineering Federation has published guidelines for the safe use of various drugs in mountain environments. The guidelines cover a range of drug types, including alcohol, steroids, and oxygen, and aim to provide evidence-based advice for medical professionals and climbers.
Researchers develop artificial cell-like spheres from natural proteins to study drug transport and variability. Variants in genes ABCB1 and CYP19A1 associated with anastrozole concentrations and joint pain in breast cancer patients.
Researchers used big data analysis to identify a previously unknown interaction between ceftriaxone and lansoprazole, increasing the risk of acquired long QT syndrome. The study used large datasets of clinical records to confirm the association, paving the way for faster data-driven approaches to identifying potential drug interactions.
Researchers discovered eight pairs of drugs associated with a higher risk of long QT syndrome, which can cause abnormal heart rhythms and sudden death. The study used big data mining to identify the interactions, and found that ceftriaxone and lansoprazole increased the risk by 1.4 times.
A new study found that Sutherlandia, a commonly used African botanical supplement, can reduce the effectiveness of isoniazid, a widely used anti-tuberculosis drug. This could lead to active tuberculosis and potentially drug-resistant forms in patients taking both supplements.
A study found that patients taking more medications before surgery and those with a history of smoking had greater long-term weight loss after gastric bypass. Preoperative insulin use was also associated with improved weight loss outcomes.
A study published in JAMA found that only 34% of patients with stable INR values while taking warfarin remained stable over the subsequent year, indicating that predicting stability is difficult. Non-vitamin K oral anticoagulants may offer improved safety and efficacy but are more costly.
A significant number of patients on clopidogrel therapy are also prescribed proton pump inhibitors (PPIs) omeprazole or esomeprazole, increasing the risk of cardiovascular events. Despite regulatory warnings, many physicians have continued to prescribe this combination.
A team of scientists has created an online resource, systemsDock, to virtually check the effectiveness and specificity of potential drugs. The tool allows users to screen multiple drugs against multiple biological targets, providing a comprehensive understanding of drug interactions with the biological system.
Researchers found that inhibiting Apolipoprotein C-III (ApoC-III) decreases triglyceride levels in blood by targeting similar pathways as LDL cholesterol. Treating mice with an ApoC-III inhibitor lowered triglycerides, but the effect was blocked in mice lacking key components of the LDL signaling pathway.
The new scientific statement highlights the potential of commonly used medications and nutritional supplements to cause or worsen heart failure. Healthcare providers should inform patients about all prescription and over-the-counter medications they may be taking, as well as nutritional supplements, to prevent drug-drug interactions.
MIT biologists identify a key protein inhibited by lithium, leading to reduced worm activity, suggesting a mechanism for lithium's effects on the brain; the findings propose a new hypothesis linking BPNT1 inhibition to mood stabilization in humans
A study led by Linköping University found that 5-hydroxymethylcytosine (HMC) is associated with several immune diseases. HMC may be used diagnostically to detect disease and personalize medication.
Recent studies suggest that nicotinic acetylcholine receptors (nAChRs) in Alzheimer's disease are influenced by direct interactions with proteins such as Lynx, NMDA-receptors, and the Wnt/β-catenin pathway. This new understanding adds complexity to cholinergic signaling in the brain and may lead to the development of targeted drugs.
Colorado State University's Brad Reisfeld and colleagues create a physiologically-based pharmacokinetic model to predict drug concentrations in the body. The model can account for individual differences and changes in metabolism, allowing for more effective treatment.
Researchers at University of Eastern Finland found that inhibiting Aurora kinase A protein can inhibit liver cancer cell growth, offering potential new treatment option. The study's findings can be used to develop treatments for patients with p53-altered liver cancer.
A team of researchers used neutron crystallography to better understand a protein implicated in HIV replication, revealing a pH-induced proton 'hopping' mechanism that guides the enzyme's activity. This understanding is vital for drug resistance and guiding rational drug design.
Researchers at Imperial College London have created a computer simulation of gene expression interactions, revealing the sequence of events that lead to genes being switched on. This breakthrough could lead to the design of molecules that interfere with or disrupt the process, potentially tackling diseases.
Researchers developed HuMiX, a human microbiome research tool that accurately models the complex interactions between human cells and bacteria. The model allows for the study of metabolic processes, including communication between the intestine and brain, and has potential applications for understanding neurodegenerative diseases.
Researchers developed gel nano-capsules that can release medicine in response to temperature changes, improving the efficiency of targeted drug delivery. The innovation overcomes existing challenges, such as aggregation and electrostatic interactions.
A Boston College research team, led by biologist Tim van Opijnen, is developing new technologies to predict drug resistance in certain bacteria and identify effective treatments. The five-year study will use cutting-edge genomics research tools and techniques to understand how bacteria interact with the immune system.
Researchers at the University of Pittsburgh School of Medicine have developed a computational model to discover new protein-protein interactions associated with schizophrenia. The study identified over 500 never-before-known PPIs, which could lead to greater understanding of the disease and its relation to other complex diseases.
A new study from the University of Sydney found that medical device and pharmaceutical companies interact with nurses, who have significant influence over hospital purchasing decisions. Nurses reported receiving gifts, product samples, and paid travel, and most acknowledged benefits in working with industry representatives.
Patients undergoing parathyroid surgery experienced fewer hip fractures and fractures of any type compared to those receiving bisphosphonates. Surgery also improved bone mineral density, while bisphosphonates had no impact on fracture risk.
A new study found that one in six older adults now regularly use potentially deadly combinations of prescription and over-the-counter medications and dietary supplements. The study identified 15 potentially life-threatening drug combinations, with nearly half involving nonprescription medications or supplements.
A new study by JAMA Network reveals that concurrent use of prescription and over-the-counter medications and dietary supplements among older adults increases the risk of major drug interactions. The study found that 15.1% of older adults in 2010-2011 were at risk for a major drug interaction, up from an estimated 8.4% in 2005-2006.
A researcher at Indiana University has been awarded $1.1 million to develop information-based tools to improve primary care for patients with chronic pain, a condition affecting 100 million Americans annually. The project aims to create prototypes for clinical decision support and electronic health record management.
Researchers at Vanderbilt University Medical Center have discovered a new compound that is more effective against the tuberculosis enzyme and maintains activity against resistant forms. The findings could lead to a more effective treatment for the deadly disease, which killed 1.5 million people in 2014.
A new study published in The Lancet Neurology confirmed that different generic antiepileptic products are equally effective in treating epilepsy, with no measurable difference found between them. This finding provides reassurance for patients and clinicians about the safety of substituting generics.
Researchers discovered that statin drugs interact with a gap junction protein called GJC3, releasing ATP and causing inflammation. The discovery provides a new target for understanding why some patients experience harmful effects like muscle toxicity when taking statins.
A new robotically driven experimentation system has been developed to determine the effects of a large number of drugs on many proteins, reducing the number of necessary experiments by 70%. The model uses an active learning approach to identify patterns and make predictions about unmeasured experiments with high accuracy.
Researchers at the University of Basel elucidated how drugs interact with cell surface proteins and transmit signals to the cellular interior. Using Nuclear Magnetic Resonance spectroscopy, they obtained unprecedented details into G protein coupled receptor function.
Negative attitudes towards aging have been shown to negatively affect both physical and cognitive health in older adults. Participants with positive attitudes exhibited improved cognitive ability. Researchers highlight the importance of societal-wide interventions targeting attitudes towards aging.
Researchers found that fluoroquinolones interact with an enzyme in TB germs, but not as strongly as thought. They discovered a new way to make the drugs more potent by targeting broken DNA within the gyrase complex. This could lead to improved treatments for multidrug-resistant TB and other bacterial infections.
A recent study found that low blood levels of bicarbonate are associated with an increased risk of premature death in healthy older adults. Participants with normal or high bicarbonate levels had a similar risk of dying compared to those with low bicarbonate levels, which was linked to a 24% higher mortality rate.
A study found that 52% of primary care physicians make unnecessary specialist referrals, with 39% prescribing brand-name drugs over generics. Physician behavior is influenced by factors like patient requests, interactions with reps, and years of experience.
Researchers at Griffith University have made a groundbreaking discovery about how bacteria interact with human cells, revealing high-affinity biomolecular interactions between glycans that were previously thought to be weak or non-existent. This finding opens up new avenues for developing vaccines and drugs to block infections.
A new study has found that combining the blood thinner warfarin with certain diabetes medications increases hospitalizations for falls, altered mental state, and insulin shock among Medicare patients. The study's findings have significant implications for patient safety and healthcare costs.
A study of 261 children with severe epilepsy found significant seizure reduction after taking pharmaceutical CBD (cannabidiol) in combination with anti-epileptic drugs. The frequency of seizures was reduced by a median of 45% in all participants, with some patients experiencing a 50% or greater reduction.
Researchers at TSRI identified a mutant protein's incorrect interactions with other cellular neighbors, which disrupted its normal function. By removing these interactions, they partially restored the protein's normal function, suggesting new therapeutic targets to treat cystic fibrosis.
A University of Alberta study found that homeless people who felt disrespected during police interactions retained negative attitudes towards police for at least two years. The study suggests teaching empathic listening and communication skills to police can improve interactions with the homeless population.
A study found that three commonly used kidney function equations yield discordant results for transplant waitlist qualification, potentially leading to significant differences in qualification time and disadvantage patients. The Cockroft-Gault equation most often disadvantaged patients compared to the MDRD and CKD-EPI equations.
A new laboratory study finds that mothers taking certain medications during pregnancy may be at risk of birth defects or stunted fetal growth. The research highlights the need for more detailed knowledge of placental drug transport to preserve fetal health.
The American Geriatrics Society released its second updated Beers Criteria, which identifies over 40 potentially problematic medications for older adults. The guidelines also provide alternative therapies and guidance on best practices for implementing recommendations.
A small study found that longer, more comprehensive interactions with complementary and integrative medicine providers significantly improve GERD symptoms. Patients receiving expanded physician visits reported greater symptom relief compared to conventional visits.
A clinical trial found that doctors given information on a patient's cognitive status provided more care focused on cognition, but this had little impact on the overall rate of cognitive decline. The study highlights the importance of primary care in recognizing cognitive impairment and supporting older adults.
A recent study published in the Journal of Geriatric Oncology found that 26% of senior oncology patients use complementary or alternative medicines, which can interact with cancer treatments. The study highlights the need for comprehensive screening and documentation of CAM use in older cancer patients.
Researchers uncover structural details of how proteins interact to turn two signals into one, enabling fine-tuning of signal and drug action. The study provides crucial insights into nuclear receptor communication, paving the way for improved drug design.
A new algorithm, DeMAND, is helping scientists identify the full repertoire of proteins affected by a drug. By analyzing gene expression changes and protein interactions, DeMAND provides a more comprehensive picture of a drug's effects.